Xenotransplantation, the practice of transplanting organs from one species into another, such as from pigs to humans, may offer a solution to the shortage of human organs. In recent years, scientists have attempted xenotransplantation multiple times, but all have ended in failure. The main reason for these failures is immune rejection, where the human body’s immune system identifies the foreign organ as a threat and attacks it. This reaction has not yet been fully controlled, making long-term success difficult. To reduce the risk of rejection, scientists have turned to genetically modified pig organs. These pigs are engineered so their organs closely resemble human ones, which helps to lower the chance of an immediate immune response. This approach has shown some success in preventing acute rejection, which happens right after the transplant. However, over time, the body still recognizes the pig organ as foreign and launches an attack, ultimately leading to organ failure. Despite these challenges, the use of pig organs as a temporary solution—known as a "bridge" until a human organ is available—may still offer hope. Researchers at Massachusetts General Hospital and Harvard University have made significant progress in this area. Their work was highlighted by the first successful case of xenotransplantation used as a bridge to human organ transplantation. This case was reported on September 3, 2026, in the medical journal The Lancet. While the dream of using pig organs as permanent replacements for human organs remains distant, these developments could save lives in the interim. Patients waiting for a compatible human organ may now have a temporary option that could keep them alive while they wait for a suitable donor. This breakthrough marks an important step forward in the field of xenotransplantation and highlights the ongoing efforts to overcome the challenges of immune rejection.